by RMCM | Jul 25, 2022 | Newsletters
In January, we noted that the S&P 500 index had finished 2021 with its second best three-year winning streak in history–and that the probability of a poor year for stocks was higher than it had been in many years. Unfortunately, that probability has become a...
by RMCM | Apr 14, 2022 | Newsletters
As of this writing, the U.S. market is almost myopically focused on inflation — and the battle to choke it off. In recent months, well-documented supply chain issues have blossomed into inflation spikes across a wide range of industries. It’s no secret that energy...
by RMCM | Jan 10, 2022 | Newsletters
Despite most expectations, stocks continued their death-defying run last year and the S&P 500 finished the year with its second best three-year winning streak in history, bested only by the late 1990s tech bubble. In the face of the highest inflation in 40 years,...
by RMCM | Oct 29, 2021 | Commentary, Newsletters
When the pandemic began, we counseled patience. In our spring Long Run of 2020, we wrote, “We cannot let immediate fear — or the constant drumbeat of bad news during this acute period of crisis — push us into poor decisions or drive us away from the fundamental...
by RMCM | Jul 22, 2021 | Commentary, Newsletters
It’s summertime, and the United States is back to taking vacations following a long period of COVID-enforced quarantines. So we’ll accept that attention spans may be short for any lengthy economic commentary, skip the verse, and go right to the chorus. Both Wall...
by RMCM | Apr 23, 2021 | Newsletters
The first quarter of 2021 has been a period of extraordinary transition. At the start of the year, the seven-day pace of vaccines administered in the United States was averaging just over 325,000 doses a day. As of this writing, the U.S. is administering more than 3...
